Natus Medical Incorporated agreed to acquire Micromed S.p.A. from ArchiMed SAS on November 2, 2022. The transaction is expected to close in early 2023, subject to the receipt of regulatory approvals. William Blair & Company, L.L.C. acted as financial advisor to ArchiMed SAS.

Luke Bergstrom, Stefano Sciolla, Olivier du Mottay, Héctor Armengod, Charles-Antoine Guelluy, Elizabeth Richards and Eveline Van Keymeulen of Latham & Watkins LLP cated as legal advisors to Natus Medical Incorporated and its associated parent of ArchiMed.